Key terms
About TWST
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TWST news
May 06
9:54am ET
Twist Bioscience price target raised to $48 from $43 at Scotiabank
May 06
9:17am ET
Twist Bioscience (TWST) Gets a Buy from Scotiabank
May 05
10:29am ET
Twist Bioscience price target raised to $28 from $25 at JPMorgan
May 05
9:55am ET
Twist Bioscience: A Sell Rating Amid Concerns Over Order Sustainability and Premium Valuation
May 03
7:35am ET
Twist Bioscience price target raised to $55 from $48 at TD Cowen
May 03
6:27am ET
Twist Bioscience price target raised to $40 from $39 at Baird
May 03
5:57am ET
Twist Bioscience price target raised to $45 from $40 at Barclays
May 02
4:24pm ET
Twist Bioscience raises FY24 revenue view to $300M-$304M from $288M-$293M
May 02
4:24pm ET
Twist Bioscience sees Q3 revenue $77M, consensus $73.8M
May 02
4:23pm ET
Twist Bioscience reports Q2 EPS (79c), consensus (82c)
May 02
2:38am ET
Twist Bioscience: Strong Demand and Strategic Positioning Fuel Buy Rating
Apr 12
8:12pm ET
Cathie Wood’s ARK Investment bought 133K shares of Twist Bioscience today
Mar 28
8:18pm ET
Cathie Wood’s ARK Investment bought 114K shares of Twist Bioscience today
Mar 25
8:17pm ET
Cathie Wood’s ARK Investment bought 129K shares of Twist Bioscience today
Mar 21
2:37am ET
Buy Rating Justified: Twist Bioscience’s Strong Demand and Strategic Expansion Signal Market Share Growth
Mar 05
1:23am ET
Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS), Twist Bioscience (TWST) and Catalent (CTLT)
Feb 08
4:41am ET
Twist Bioscience Shareholders Elect Directors, Approve Compensation
Feb 07
10:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Walgreens Boots Alliance (WBA) and Twist Bioscience (TWST)
No recent press releases are available for TWST
TWST Financials
Key terms
Ad Feedback
TWST Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TWST Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
